PepFellas Laboratories | Research-Grade Peptides
PEPFELLAS Laboratories • Est. 2026
Research Wiki / Peptide Profile
Peptide Profile

ARA-290 (Cibinetide)

ARA-290, also known generically as Cibinetide, is a synthetic 11-amino-acid peptide engineered from the helix B surface domain of human erythropoietin (EPO).

1. Chemical Structure and Biochemistry

ARA-290 is a non-hematopoietic EPO analogue.

  • Peptide Sequence: Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
  • Structural Modification: The peptide is specifically truncated and modified (featuring an N-terminal pyroglutamate) to separate the tissue-protective properties of EPO from its blood-building properties, bypassing the classical EPO receptor that causes cardiovascular risks at high doses.

2. Mechanism of Action

ARA-290 specifically targets the Innate Repair Receptor (IRR), a heteromeric complex comprised of the EPO receptor (EPOR) and the beta-common receptor (CD131).

  • Anti-inflammatory: Activation of the IRR turns off the production of pro-inflammatory cytokines (like TNF-alpha) by macrophages.
  • Tissue Repair: Stimulates the healing and survival of cells subjected to stress, hypoxia, or injury.

3. Research and Applications

The peptide has been a major focus in clinical research regarding neuropathic pain and immune-mediated diseases.

  • Neuropathy & Nerve Repair: Heavily researched for small fiber neuropathy, particularly in patients with Type 2 Diabetes or Sarcoidosis, showing potential to promote nerve fiber regrowth.
  • Autoimmune & Inflammatory Conditions: Explored for treating conditions involving chronic systemic inflammation.
Tags: ARA-290 Cibinetide helix-B-surface-peptide Innate-Repair-Receptor IRR erythropoietin-analogue non-hematopoietic-EPO neuropathy nerve-repair sarcoidosis anti-inflammatory-peptide